Advertisement
Screener

AVALO THERAPEUTICS, INC. (AVTX) EBITDA

AVALO THERAPEUTICS, INC. (AVTX) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$31.50M*; Operating income -$31.52M; Depreciation and amortization $17.00K*.
  • 2026-03-31: Basis Reported; EBITDA -$20.88M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$19.73M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$19.14M*; Operating income -$19.20M; Depreciation and amortization $59.00K*.

Complete source-backed ebitda history.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$31.50M*-$31.52M$17.00K*(m)(m)(m)-$19.99M*(m)(m)(m)$18.00K
2026-03-31Reported-$20.88M(m)(m)(m)(m)(m)-$17.69M(m)(m)(m)$12.00K
2025-12-31Reported-$19.73M(m)(m)(m)-33433.90%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$19.14M*-$19.20M$59.00K*$0.00(m)(m)-$16.36M*(m)(m)(m)$11.00K
2025-06-30Reported-$19.18M*-$19.32M$134.00K*(m)(m)(m)-$11.39M*$0.00(m)(m)$16.00K
2025-03-31Reported-$14.53M(m)(m)(m)(m)(m)-$9.46M(m)(m)(m)$8.00K
2024-12-31Reported-$13.24M(m)(m)(m)-6897.40%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$12.83M*-$12.86M$34.00K*$249.00K-5151.41%*(m)-$11.53M*-$714.00K(m)(m)-$14.00K
2024-06-30Reported-$9.54M*-$9.57M$33.00K*$0.00(m)(m)-$16.28M*$343.00K(m)(m)$7.00K
2024-03-31Reported-$32.73M(m)(m)(m)(m)(m)-$6.20M-$80.00K(m)(m)$7.00K
2023-12-31Reported-$7.62M(m)(m)(m)-1333.63%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$3.71M*-$3.75M$41.00K*$236.00K-1571.61%*(m)-$6.84M*$247.00K(m)$2.49M$8.00K
2023-06-30Reported-$7.11M*-$7.15M$41.00K*$643.00K-1105.60%*(m)-$11.03M*$708.00K(m)$2.43M$7.00K
2023-03-31Reported-$8.76M(m)(m)(m)-1844.00%(m)-$10.05M$551.00K(m)$2.71M$8.00K
2022-12-31Reported-$8.82M(m)(m)(m)-984.38%(m)(m)(m)(m)(m)(m)
2022-09-30Reported$4.13M*$4.09M$34.00K*$14.95M27.62%*$39.00K*$5.73M*$528.00K(m)$3.28M$5.00K
2022-06-30Reported-$11.80M*-$11.83M$30.00K*$1.03M-1142.11%*$56.00K*-$12.47M*$1.57M(m)$2.78M$5.00K
2022-03-31Reported-$20.79M(m)(m)(m)-1772.04%$0.00-$16.07M$720.00K(m)$11.68M$9.00K
2021-12-31Reported-$17.67M(m)(m)(m)-8067.58%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$16.01M*-$16.46M$455.00K*$1.35M-1185.78%*$81.00K*-$16.29M*$908.00K(m)$5.93M$8.00K
2021-06-30Reported-$16.67M*-$17.13M$456.00K*$3.35M-496.96%*$0.00*-$19.19M*$83.00K(m)$7.40M-$199.00K
2021-03-31Reported-$30.13M(m)(m)(m)-6369.77%$21.00K-$18.32M$77.00K$2.50M(m)$11.00K
2020-12-31Reported-$15.8M(m)(m)(m)-1055.51%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$12.85M*-$13.28M$426.00K*$1.11M-1156.71%*$63.00K*-$11.87M*$77.00K(m)(m)$3.00K
2020-06-30Reported-$11.39M*-$11.81M$426.00K*$1.34M-851.20%*$0.00*-$8.55M*$78.00K(m)(m)-$454.00K
2020-03-31Reported-$30.96M(m)(m)(m)-1124.18%$0.00-$5.74M$66.00K(m)(m)-$2.16M
2019-12-31Reported-$5.11M(m)(m)(m)-879.05%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$1.80M*-$2.86M$1.06M*$2.20M-81.71%*$5.08K*-$7.62M*$132.38K(m)(m)$121.64K
2019-06-30Reported-$1.44M*-$2.55M$1.10M*$1.39M-103.68%*$90.96K*-$6.72M*-$1.50M(m)(m)$53.45K
2019-03-31Reported-$3.91M(m)(m)(m)-151.63%$165.97K-$3.12M$752.55K$3.40M(m)$130.67K
2018-12-31Reported-$336,465.00(m)(m)(m)5.33%(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$23.24M*-$24.31M$1.07M*$4.07M-570.40%*$39.13K*-$538.35K*$3.11M(m)(m)$52.41K
2018-06-30Reported-$4.51M*-$5.75M$1.24M*$4.79M-94.32%*$6.71K*-$333.67K*$1.42M$1.08M(m)$16.35K
2018-03-31Reported-$2.73M(m)(m)(m)-60.93%$19.22K-$280.42K$863.62K$1.65M(m)$23.31K
2017-12-31Reported-$3.95M(m)(m)(m)-176.79%(m)(m)(m)(m)(m)(m)
2017-09-30Reported$21.93M*$21.92M$5.36K*$25.04M87.57%*$6.19K*$19.12M*$0.00$965.00K(m)$3.23M
2017-06-30Reported-$1.77M*-$1.77M$5.86K*$157.80K-1121.13%*$0.00*-$1.76M*$0.00$493.65K(m)$0.00
2017-03-31Reported-$1.89M(m)(m)(m)-493046.61%$1.80K-$2.24M(m)$953.07K(m)$0.00
2016-09-30Reported(m)-$5.96M(m)(m)(m)$6.49K*(m)(m)$4.58M(m)$0.00
2016-06-30Reported(m)-$3.49M(m)(m)(m)$10.26K*(m)(m)$2.50M(m)(m)
2016-03-31Reported(m)-$4.94M(m)(m)(m)$8.90K(m)(m)$2.29M(m)(m)
2015-09-30Reported(m)-$1.96M(m)(m)(m)(m)(m)(m)$1.24M(m)(m)
2015-06-30Reported(m)-$2.89M(m)(m)(m)(m)(m)(m)$1.88M(m)(m)
2015-03-31Reported(m)-$2.48M(m)(m)(m)(m)(m)(m)$1.72M(m)(m)
2014-09-30Reported(m)-$6.00M(m)(m)(m)(m)(m)(m)$4.37M(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$72.58M(m)(m)(m)-123018.64%(m)-$51.46M(m)(m)(m)$165.00K
2024-12-31Reported-$68.34M(m)(m)(m)-15497.28%(m)-$49.06M(m)(m)(m)$114.00K
2023-12-31Reported-$27.19M(m)(m)(m)-1413.36%(m)-$30.68M$1.28M(m)$10.30M$14.00K
2022-12-31Reported-$37.27M(m)(m)(m)-206.49%$95.00K-$26.75M$3.43M(m)$20.71M$28.00K
2021-12-31Reported-$80.48M(m)(m)(m)-1490.87%$113.00K-$70.89M$1.49M(m)(m)-$196.00K
2020-12-31Reported-$71M(m)(m)(m)-1059.86%$63.00K-$40.54M$300.00K(m)(m)-$2.79M
2019-12-31Reported-$12.25M(m)(m)(m)-181.53%$262.01K-$19.13M-$566.52K(m)(m)$280.32K
2018-12-31Reported-$30.82M(m)(m)(m)-438.56%$564.41K-$3.13M$3.26M$5.79M(m)-$49.47K
2017-12-31Reported$14.32M(m)(m)(m)51.47%$23.32K$12.58M$635.65K$4.37M(m)$1.97M
2016-12-31Reported-$16.05M(m)(m)(m)-1392.31%$34.88K-$14.57M(m)$10.15M(m)$0.00
2015-12-31Reported-$10.99M(m)(m)(m)(m)$19.98K-$10.16M(m)$6.59M(m)$0.00
2014-12-31Reported(m)-$17.12M(m)(m)(m)$19.50K(m)(m)$12.24M(m)(m)
2013-12-31Reported(m)-$12.93M(m)(m)(m)$29.27K(m)(m)$8.91M(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
ARDELYX, INC. (ARDX)United States$0.857B-22.86
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
GERON CORP (GERN)United States$0.803B-12.14
Cryoport, Inc. (CYRX)United States$0.881B-21.29
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25